期刊文献+

短发夹RNA抑制喉癌细胞hTERT基因表达及诱导细胞凋亡 被引量:1

Inhibition of human telomerase reverse transcriptase and induction of apoptosis in laryngeal carcinoma cells by short hairpin RNA
下载PDF
导出
摘要 目的:探讨DNA载体途径的RNA干扰技术抑制人端粒酶逆转录酶(hTERT)基因表达及诱导喉癌细胞Hep-2凋亡的作用。方法:构建靶向hTERTmRNA的质粒pshRNA1、pshRNA2及对照质粒pshRNA3、pEGFP,并将其分别转染喉鳞癌Hep-2细胞。共聚焦荧光显微镜观察质粒转染及表达情况;RT-PCR测定hTERTmRNA表达;Western印迹测定hTERT蛋白表达;末端重复片断扩增-酶联免疫吸附(TRAP-ELISA)方法测定细胞端粒酶活性;MTT法研究细胞增殖活性变化;原位细胞凋亡(TUNEL)及透射电子显微镜研究细胞凋亡。结果:①共聚焦荧光显微镜下见大量的细胞呈现绿色荧光,与其他组比较,pshRNA1、2组呈现荧光的死亡细胞显著增加。②pshRNA1、2转染细胞后hTERTmRNA及hTERT蛋白表达显著降低;其端粒酶活性明显受到抑制:转染后2 d pshRNA1组活性为:0.159±0.039、pshRNA2组活性为0.163±0.028,与空白对照组1.523±0.076比较,差异有非常显著性(P<0.005)。③pshRNA1、2转染细胞后可显著抑制细胞增殖、诱导细胞凋亡。这两组细胞透射电镜可见典型细胞凋亡特征。结论:DNA载体途径的RNA干扰技术能有效抑制hTERT基因的表达及端粒酶活性并诱导癌细胞凋亡,此法可能成为抑制肿瘤细胞的新途径。 Objective:To suppress human telomerase reverse transcriptase (hTERT) expression an vector-based RNA interference d induce apoptosis of laryngeal carcinoma Hep-2 cells by using DNA(RNAi) technology. Methods: Short hairpin RNA expression vectors targeting the mRNA of hTERT (pshRNA1 and pshRNA2) and the control vector (pshRNA3 and pEGFP) were constructed and then transfected into laryngeal carcinoma Hep-2 cells. Plasmid transfection and gene expression were observed by confocal laser microscopy. The mRNA expression and protein expression of hTERT were determined by reverse-trans criptase polymerase chain reaction and western blotting, respectively. The activity of telomerase was measured by telomeric repeated amplification enzyme-linked immunosorbent assay (TRAP-ELISA). Cell viability was evaluated by 3-(4,5-dimethyl thiazol-2-yl) 2,5-diphenyl tetrazolium bromide (MTT) assay. Cell apoptosis was detected by TUNEL staining and transmission electron microscope. Results.. ① The strong intensity of green fluorescence was observed indicating there were many dead cells in pshRNA1 and pshRNA2 groups than that in control group. ②hTERT mRNA and protein expressions in pshRNA1 and pshRNA2 groups significantly decreased. The activity of telomerase in these two groups were markedly inhibited (pshRNA1 : 0.159 ± 0.039; pshRNA2: 0.163±0. 028, control: 1. 523±0.076. P〈0.005). ③Transfections of Hep-2 cells with pshRNA1 and pshRNA2 significantly inhibited proliferation and induced apoptosis of Hep-2 cells. The cells in two groups above showed typical apoptotic characteristics. Conclusion.. The expression of hTERT and the activity of telomerase were efficiently suppressed by using DNA vector-based RNA interfering technology. It can be a new strategy for the treatment of laryngeal carcinoma.
出处 《肿瘤》 CAS CSCD 北大核心 2006年第9期798-804,共7页 Tumor
基金 国家自然科学基金资助项目(编号:30471873)
关键词 喉肿瘤 端粒末端转移酶 RNA干扰 细胞凋亡 HEP-2细胞 端粒酶逆转录酶 Laryngeal neoplasms Telomerase, RNA interference Apoptosis Hep-2 cells Telomerase reverse transcriptase
  • 相关文献

参考文献11

  • 1SMOLIKOVS,MAZOR Y,KRAUSKOPF A. ELGI,a regulator of genome stability, has a role in telomere length regulation and in silencing[J]. Proc Natl Acad Sci USA, 2004,101(6):1656-1661. 被引量:1
  • 2STEWART S A. Multiple levels of telomerase regulation[J]. Mol Interv, 2002,2 (8) : 481-483. 被引量:1
  • 3BOLDRINI L,FAVIANA P,GIFREDI S,et al. Regulation of telomerase and its hTERT messenger in colorectal cancer [J]. Omcol Rep, 2004,11 (2) : 395-400. 被引量:1
  • 4MEYERSON M,COUTER C M, EATON E N,et al. hESTZ, the putatire human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization[J]. Cell, 1997,90(4) :785-795. 被引量:1
  • 5BRUMMEI.KAMP TR,BERNARDS R,AGAMI R. A system for stable expression of short interfering RNAs in mammalian cells[J]. Science,2002,296(5567) : 550-553. 被引量:1
  • 6HANNON G J. RNA interference[J]. Nature, 2002,418(6894) :244-251. 被引量:1
  • 7GELEY S, MULLER C. RNAi:ancient mechanism with a promising future[J]. Exp Gerontol, 2004,39 (7) : 985-998. 被引量:1
  • 8KRAMS M,CLAVIEZ A, HEIDORN K,et al. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas[J]. Am J Pathol,2001,159(5): 1925-1932. 被引量:1
  • 9VERMA UN,SURABHI RM,SCHMALTIEG A,et al. Small interfering RNAs directed against beta catenin inhibit the in vitro and in vivo growth of colon cancer cells[J]. Clin Cancer Res ,2003,9(4): 1291-1300. 被引量:1
  • 10陈学军,郑伟,王升启.人端粒酶催化亚基反义核酸对子宫内膜癌细胞的抑制作用[J].中华肿瘤杂志,2003,25(3):212-215. 被引量:11

二级参考文献7

  • 1Satoro K, Taro K, Masahiro T, et al. Human telomerase reverse transcriptase as a critical deter minant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer, 1999, 80:60-63. 被引量:1
  • 2Kim NW. Specific association of human telomerase activity with immotal cells and cancers(sece comments). Science, 1994,266:2011. 被引量:1
  • 3Douglas WG, Haeri R, James P, et al. Atisense oligonucleitides: an evolving technology for the modulation of gene expression in human disease. J Am Coll Surg, 2000,191: 93-105. 被引量:1
  • 4Yasuhiro Y, Yuichiro T. The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to supress telomerase activity. Biochem Biophys Res Comm, 2000, 273:316-321. 被引量:1
  • 5Yokoyama Y, Takahashi Y, Shonahara A, et al. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res, 1998,58:5406-5410. 被引量:1
  • 6Norton JC, Piatyszek MA, Wright WE, et al. Inhibition of human telomerase activity by peptide nucleic acids. Nat Biotechnol,1996,14: 615-619. 被引量:1
  • 7Yasuhiro Y, Uichiro T. The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to supress telomerase activity. Biochem Biophys Res Comm, 2000,273:316-321. 被引量:1

共引文献10

同被引文献13

  • 1平浩,张军晖,陈晓春,鲁功成.hTERT短发夹状RNA抑制前列腺癌细胞生长的研究[J].肿瘤防治研究,2007,34(2):128-131. 被引量:1
  • 2Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? [J]. Oneogene,2002,21 (4):688-697. 被引量:1
  • 3Yano Y, Yoshida K, Osaki A, et al. Expression and distribution of human telomerase catalytic component, hTERT, in hu man breast tissues[J]. Anticancer Res, 2002,22 (6C) :4101- 4107. 被引量:1
  • 4Elkak A, Mokbel R, Wilson C, et al. hTERT mRNA expression is associated with a poor clinical outcome in human breast cancer[J]. Anticancer Res, 2006,26 (6C): 4901-4904. 被引量:1
  • 5Salhab M, Jiang WG, Newbold R F, et al. The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcomeFJ 1. Breast Cancer Res Treat, 2008, 109 ( 1 ) : 35-46. 被引量:1
  • 6Sui G, Soohoo C, Affar El B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells[J]. Proc Nail Acad Sci USA,2002,99(8) : 5515-5520. 被引量:1
  • 7Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identi fication of proximal core promoter sequences essential for tran scriptional activation in immortalized and cancer cells[J]. Cancer Res, 1999,59(3) :551-557. 被引量:1
  • 8Cerni C. Telomeres, telomerase, and myc. An update[J]. Murat Res,2000,462(1) : 31-47. 被引量:1
  • 9Karrmlori M, Izumiyama N, Hashimoto M, et al. Expression of human telomerase reverse transeriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy [J]. Int J Oncol, 2005,27 (5) : 1257 1263. 被引量:1
  • 10Song JS, Kim HP. Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small ceil lung cancer cell line[J]. Oncol Rep,2004, 12(2) :443- 447. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部